Proinsulin C-peptide inhibits lipolysis in diabetic rat adipose tissue through phosphodiestrase-3B enzyme.

@article{Ghorbani2013ProinsulinCI,
  title={Proinsulin C-peptide inhibits lipolysis in diabetic rat adipose tissue through phosphodiestrase-3B enzyme.},
  author={Ahmad Ghorbani and Gholamhossein Ranjbar Omrani and Mousa-Al-Reza Hadjzadeh and Masoumeh Varedi},
  journal={Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme},
  year={2013},
  volume={45 3},
  pages={
          221-5
        }
}
  • A. GhorbaniG. Omrani M. Varedi
  • Published 18 September 2012
  • Biology
  • Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
We have previously reported that C-peptide modulates insulin-mediated inhibition of lipolysis and glucose consumption but has no significant effects per se on adipose tissue of normal rats. It has been repeatedly observed that certain actions of C-peptide are restricted to the diabetic states. In the present study, therefore, we examined whether C-peptide alters lipolysis in adipose tissue of diabetic rats. Rats were rendered diabetic by streptozotocin and divided into 2 groups; insulin treated… 

Figures and Tables from this paper

Physiological effects of proinsulin-connecting peptide in human subcutaneous adipose tissue.

It is suggested that C-peptide has some physiological effects in human subcutaneous adipose tissue and contributes to the regulation of basal lipolysis and pool of MSCs.

MC2, a new phosphodiesterase-3 inhibitor with antilipolytic and hypolipidemic effects in normal and diabetic rats

Selective PDE3 inhibitors are considered as useful pharmacological agents with variety of inotropic, vasodilatory, anti-thrombotic, anti-inflammatory, and insulin secretory effects. Yet, metabolic

C-peptide corrects hepatocellular dysfunction in a rat model of type 1 diabetes

It is concluded that C-peptide could be used as an alternative therapy to insulin to correct hepatocellular dysfunction associated with type 1 diabetes mellitus (T1DM).

Effects of Securigera securidaca Extract on Lipolysis and Adipogenesis in Diabetic Rats

S. securidaca decreases lipolysis and adipogenesis without cytotoxicity, which makes it a good candidate for management of dyslipidemia and reduction of cardiovascular risks in diabetes.

Proinsulin C-peptide and its C-terminal fragments stimulate Gi/o-proteins but do not influence adenylyl cyclase activity

It is suggested that C-peptide and its terminal fragments can inhibit AC and suppress cAMP-dependent signaling cascades in cells and be homologous to Gi/oand Gq/11protein-coupled receptors of peptide hormones.

Protective effects of either C‐peptide or l‐arginine on pancreatic β‐cell function, proliferation, and oxidative stress in streptozotocin‐induced diabetic rats

The results showed that induction of diabetes caused hyperglycemia, dyslipidemia, and oxidative stress, but administration of C‐peptide or l‐arginine significantly improved the pancreatic histopathology with a significant increase in the area % of insulin immunoreactivity, the number of PCNA immunopositive cells, theNumber of islets, and the diameter of islet compared with the diabetic group.

Metabolic effects of newly synthesized phosphodiesterase-3 inhibitor 6-[4-(4-methylpiperidin-1-yl)-4-oxobutoxy]-4-methylquinolin-2(1H)-one on rat adipocytes

The data indicate that selective PDE3 inhibitors produce differential effects on adipogenesis and lipolysis and MC2 has lowest metabolic side effects and might be a good candidate for treatment of congestive heart failure.

Effects of fenugreek seeds on adipogenesis and lipolysis in normal and diabetic rats.

It is demonstrated that fenugreek seed inhibits formation of new differentiated adipocytes from precursor cells through an anti-proliferative effect on preadipocytes.

Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.

Evidence is provided that bosentan treatment is associated with promising hepatoprotective effect against diabetes-induced liver damage via reduction of cell inflammation and oxidative damage, and blockage of these receptors may become a target for preventing diabetic complications in the future.

Research Progress of C-Peptide and Its Physiological Function

The effects of C- peptide on diabetic complications, reproductive endocrine system, blood system, tissue repair, and neoplastic diseases were reviewed to provide references for further clarification of c-peptide related problems.

References

SHOWING 1-10 OF 35 REFERENCES

ects of Rat C-peptide-II on Lipolysis and Glucose Consumption in Cultured Rat Adipose Tissue

The data suggest that CP may conditionally modulate certain metabolic actions of insulin in RP adipose tissue, which may contribute to fi ne-tuning of body metabolism under physiologic or pathologic conditions.

Molecular basis for the insulinomimetic effects of C-peptide

C-peptide could modulate the metabolic effects of insulin by enhancing them at low hormone concentrations and dampening them at high hormone concentrations, and it is speculated that the same signalling elements are used by both ligands.

Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.

In KO mice, liver triglyceride and cAMP contents were increased, and the liver content and phosphorylation states of several insulin signaling, gluconeogenic, and inflammation- and stress-related components were altered, suggesting PDE3B may be important in regulating certain cAMP signaling pathways, including lipolysis, insulin-induced antilipolysis and camp-mediated insulin secretion.

The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis Published, JLR Papers in Press, December 16, 2004. DOI 10.1194/jlr.M400362-JLR200

Simultaneous exposure to cilostamide and rolipram had a synergistic effect on lipolysis in murine 3T3-L1 and rat adipocytes but not in human adipocytes, indicating the relative importance of PDE3 and PDE4 in regulating lipolytic activity differed in cultured murine, rat, and human adip cells.

Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats

Physiological concentrations of homologous C peptide stimulate whole body glucose utilization in diabetic but not in healthy rats, and the influence of C peptides on glucose utilization may be mediated by nitric oxide.

Human fat cell lipolysis: biochemistry, regulation and clinical role.

  • P. Arner
  • Biology, Medicine
    Best practice & research. Clinical endocrinology & metabolism
  • 2005

Effect of diet on fat cell size and hormone-sensitive lipase activity.

It is demonstrated that an attenuated HSL activity is not observed with the onset of insulin resistance/hyperinsulinemia and therefore does not play a role in the development of obesity.

C‐peptide: new findings and therapeutic implications in diabetes

  • J. Wahren
  • Biology, Medicine
    Clinical physiology and functional imaging
  • 2004
Continuing research is needed to establish whether, among the hormones from the islets of Langerhans, C‐peptide is the ugly duckling that may prove to be an endogenous peptide hormone of importance in the treatment of diabetic long‐term complications.

C-Peptide: Much More Than a Byproduct of Insulin Biosynthesis

An up-to-date review of C-peptide, focusing on its role in insulin biosynthesis and in the classification of diabetes mellitus, as well as its potential clinical applications, and the findings that pancreas transplants promote the reversal of diabetic neuropathy and stabilization of diabetic retinopathy lend credence to the concept that combined replacement of insulin and C- peptide may more effectively mitigate the inexorable progression of diabetes-related complications.